Plastic bronchitis (PB) is a relatively unknown condition where mucin or fibrin casts develop in the bronchial tree resulting in airway obstruction. It is commonly seen within the realms of pediatric cardiology and pulmonology. Some common etiologies include sickle cell disease, asthma, cystic fibrosis, and congenital heart disease. Mortalities of PB cases associated with congenital heart disease range from 29% to 60%.A five-year-old patient with single ventricle physiology underwent the Fontan procedure and presented with PB after two months, earlier than the reported mean of 2.2 years to 2.8 years.1,2 He had normal hemodynamics on cardiac catheterization and casts with an unusual histology. Our case is unique because a majority of post-Fontan PB had acellular mucinous casts, but our patient's casts consisted of mucin, fibrin, and inflammatory cells. Secondly, our patient had normal extra-cardiac Fontan mean pressure of 11 mmHg, which is lower than the average Fontan mean pressure described in the literature.Our case highlights respiratory tract inflammation as a trigger for PB episodes in the setting of normal pulmonary artery pressure (PAP). Thus, we propose keeping in mind other risk factors for PB following Fontan procedure despite normal PAP so that early bronchoscopy will be performed, and therapies can be started as soon as possible. Finally, the utility of prophylactic antimicrobials to prevent PB episodes for patients with normal BP should be investigated.Plastic bronchitis (PB) is a relatively unknown condition where mucin or fibrin casts develop in the bronchial tree resulting in airway obstruction. It is commonly seen within the realms of pediatric cardiology and pulmonology and some common etiologies include sickle cell disease, asthma, cystic fibrosis, and congenital heart disease. Long-term mortalities of PB cases associated with congenital heart disease range from 29% reported by Brogan et al. 4 to 33% reported by Madsen et al., 8 and acute mortalities are as high as 60% (3 out of 5 patients reported by Seear et al.).3 Median time to death from PB diagnosis is 0.4 years.2 This case presentation is an opportunity to educate the medical community on early recognition of PB as early diagnosis and treatment are key to reducing its high mortality rate. Prior to diagnosis, patients with PB present